Atlas Trials

BioSyngen Pte Ltd

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch BioSyngen Pte Ltd

RecordFirmDate
BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies (NCT06645301)BioSyngen Pte Ltd2024-11-30
Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma (NCT06645314)BioSyngen Pte Ltd2024-11-30
A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer (NCT06643910)BioSyngen Pte Ltd2024-10-24
A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer (NCT06526832)BioSyngen Pte Ltd2024-07-04
Investigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection in the Treatment of Locally Advanced/Metastatic Liver Cancer (NCT06173726)BioSyngen Pte Ltd2023-12-05
BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors (NCT06152757)BioSyngen Pte Ltd2023-10-09
A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NCT05864924)BioSyngen Pte Ltd2023-05-10
A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites (NCT03736122)BioSyngen Pte Ltd2019-01-01

Track BioSyngen Pte Ltd automatically

Every clearance here is in the API, with alerts when new ones post.